A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2− early breast cancer in the United States

Peer Review reports

Original Submission
20 Jul 2021	Submitted	Original manuscript
4 Sep 2021	Reviewed	Reviewer Report
20 Oct 2021	Reviewed	Reviewer Report
18 Mar 2022	Author responded	Author comments - Jacqueline Brown
Resubmission - Version 2
18 Mar 2022	Submitted	Manuscript version 2
24 Mar 2022	Reviewed	Reviewer Report
4 Apr 2022	Reviewed	Reviewer Report
12 Apr 2022	Author responded	Author comments - Jacqueline Brown
Resubmission - Version 3
12 Apr 2022	Submitted	Manuscript version 3
Publishing
17 Apr 2022	Editorially accepted
6 May 2022	Article published	10.1186/s12885-022-09557-6

Back to article page